Showing results (311-320 of 322) with videos related to
Sort By:
Pageof 33
International Journal of Hematology|September 15, 2010
Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2019
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell LymphomaAnas Younes, Laurie H Sehn, Peter Johnson, et al.Cancer Research and Treatment|January 3, 2023
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)Hyungwoo Cho, Dok Hyun Yoon, Dong-Yeop Shin, et al.Asia-Pacific Journal of Clinical Oncology|March 14, 2023
Radioimmunotherapy with 131 I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphomaYoon Jung Jang, Sang Moo Lim, Inki Lee, et al.Annals of Hematology|July 25, 2021
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter studyWon Seog Kim, Yasuhiro Oki, Seok Jin Kim, et al.Frontiers in Oncology|September 7, 2023
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantationSeok Jin Kim, Jae-Cheol Jo, Dok Hyun Yoon, et al.The Lancet. Oncology|February 14, 2016
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysisSeok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard, et al.Oncotarget|October 8, 2016
Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort studySeok Jin Kim, Jun Sik Hong, Myung Hee Chang, et al.Oncotarget|December 2, 2017
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphomaJunshik Hong, Seok Jin Kim, Myung Hee Chang, et al.Cancer Research and Treatment|April 25, 2022
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean CohortsJun Ho Yi, Seong Hyun Jeong, Seok Jin Kim, et al.Pageof 33